Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (ZNTL)

CUSIP: 98943L107

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Common Stock,$0.001 par value per share
Shares outstanding
72,096,078
Total 13F shares
85,290,558
Share change
+4,205,796
Total reported value
$1,344,227,610
Put/Call ratio
3.4%
Price per share
$15.76
Number of holders
140
Value change
+$67,005,140
Number of buys
75
Number of sells
49

Quarterly Holders Quick Answers

What is CUSIP 98943L107?
CUSIP 98943L107 identifies ZNTL - Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (ZNTL) as of Q1 2024

As of 31 Mar 2024, Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (ZNTL) was held by 140 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 85,290,558 shares. The largest 10 holders included Matrix Capital Management Company, LP, EVENTIDE ASSET MANAGEMENT, LLC, FMR LLC, BlackRock Inc., VANGUARD GROUP INC, CITADEL ADVISORS LLC, STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, T. Rowe Price Investment Management, Inc., and Capital International Investors. This page lists 140 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.